723 analytical development jobs at 406 companies in Fall River, MA
2mo
Save
Mark Applied
Hide
2mo
Director, Analytical Development
Cambridge, Massachusetts, United States
$225k-$245k/yrOnsiteFull Time
Stylus Medicine: Develops in vivo genetic medicines with recombinases and nanoparticles.
10+ YOEPhD in Biochemistry, Molecular Biology, or Chemical/Biological Engineering with 10+ years in analytical method development, validation, and regulatory submissions.
NGS, RNA-seq, ddPCR, RT-PCR, ELISA, DLS, LC, UV, MS
ArdelyxNASDAQ: ARDX: Discovers and develops medicines for unmet medical needs.
10+ YOEBachelor's in chemistry or related field, 10+ years industry experience, strong analytical chemistry and cGMP experience, regulatory document preparation, outsourced partner management, budget and cross-functional collaboration skills.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
2+ YOEExperience in analytical method development/validation with chromatography techniques; PhD+2yrs or MS+5yrs (or BS+8yrs); strong data interpretation, troubleshooting, GMP knowledge, and communication skills.
Aurion Biotech: Developing regenerative cell therapies to restore vision for patients.
3+ YOEPhD (3–5 years) or MS (6–8 years) in related field with demonstrated analytical development experience for cell therapies; deep technical knowledge of assays (Flow Cytometry, dPCR/qPCR, ELISA, potency) and GMP method development; strong cross-functional collaboration and documentation skills.
Celldex TherapeuticsNASDAQ: CLDX: Developing antibody-based immunotherapies for inflammatory and autoimmune diseases.
8+ YOE8+ years analytical development experience, BS in biology/biotech (MS preferred), experience with protein analytics, ELN and lab software, strong documentation, communication and leadership skills.
Curia: Contract manufacturing and research services for biopharmaceutical companies.
1+ YOEMethod development and analysis of biological molecules; expertise with ELISA, cIEF, CE-SDS, HPLC/UPLC, qPCR, PA800; 1+ years relevant experience (varies by degree); ability to author reports and investigations.
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
4+ YOEExperienced in development and qualification of cell-based assays, mammalian cell culture, flow cytometry, sequencing platforms, and statistical analysis; Ph.D. or equivalent industry experience and ability to lead assay lifecycle and tech transfer.
flow cytometry, droplet digital PCR, sanger sequencing, amplicon next generation sequencing, JMP, GraphPAD, Qubas, Softmax, FlowJo, MACSQuantify
Cogent BiosciencesNASDAQ: COGT: Develops precision therapies for genetically defined diseases
8+ YOEPhD+8 years (or MS+10 or BS+12) in a scientific discipline, strong analytical development and CMC documentation experience, knowledge of HPLC/UPLC, GC, mass spectrometry, stability testing, regulatory requirements, and technical writing.
HPLC/UPLC, GC, dissolution, spectroscopy, mass spectrometry, particle size analysis
Relay TherapeuticsNASDAQ: RLAY: Develops precision medicines by analyzing dynamic protein motion.
8+ YOEPhD/MS/BS in analytical chemistry, biotechnology, or related field with substantial industry experience; expertise in small-molecule analytical method development, validation, QC oversight, and regulatory guidelines.
Senior Director, Analytical Development & Quality Control
Boston, Massachusetts, United States
$210k-$370k/yrHybridFull Time
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
12+ YOEPhD preferred (or MS) with ~12+ years experience in analytical development; deep expertise in method development/validation/transfer, HPLC/UPLC, mass spectrometry, cGMP, and global regulatory submissions; demonstrated leadership managing analytical/QC groups.
Metaphore Biotechnologies: Designs biological therapeutics using a mimic-discovery platform.
Current Northeastern student (Bachelors or Masters) in related STEM fields, GPA ≥3.5, hands-on lab skills applicable to analytical assays, strong communication, record-keeping, and data analysis abilities.
Associate Director, Analytical Development – Small Molecule
Boston, Massachusetts, United States
$180k-$195k/yrOnsiteFull Time
Centessa PharmaceuticalsNasdaq: CNTA: Develops therapeutic candidates using an asset-centric research model.
10+ YOEPhD or MS in chemistry/pharmaceutical sciences, 10+ years small-molecule industry experience across early to late development, cGMP and ICH knowledge, stability and analytical method expertise, vendor and CDMO management, domestic and international travel required.
Analytical Characterization Development Scientist - LNPs
Boston, Massachusetts, United States
$37-$41/hrOnsiteFull Time
Eurofins ScientificEuronext Paris: ERF: Global provider of analytical testing and laboratory services.
3+ YOEB.S. in a related field with 3+ years biotech experience; proficiency with HPLC/LCMS/Capillary Electrophoresis and Waters/Agilent LCs; experience with OpenLab, Empower, ELN; method development/validation for mRNA/LNP.
Zealand PharmaNasdaq Copenhagen: ZEAL: Develops peptide-based medicines for obesity and metabolic health.
Advanced degree in Chemistry/Chemical Engineering (PhD preferred), extensive peptide process development experience, leadership of global technical teams, expertise in peptide synthesis, process optimization, technology transfer, and CMO interactions.
Associate Director, Analytical Development & Quality Control
Boston, Massachusetts, United States
OnsiteFull Time
Alpha-9 Oncology: Developing targeted radiopharmaceuticals for the treatment of cancer
8+ YOE5+ MgmtPh.D. with ≥8 years or M.S. with ≥11 years in analytical chemistry/radiochemistry; ≥5 years managing CDMOs; experience with analytical method lifecycle, investigations, OOS/OOT, CAPA, and cGMP/ICH requirements.
AmgenNASDAQ: AMGN: Develops and manufactures biotechnology medicines for serious diseases.
3+ YOEPhD (or MS +3 yrs or BS +5 yrs) in a relevant science; experience in analytical method development, small molecule analysis, chromatography, mass spectrometry, NMR, solid-state characterization; familiarity with GLP/GMP; strong communication and technical writing.
HPLC, UPLC, Mass spectrometry, Chromatography, UV, NMR, FTIR
Zealand PharmaNasdaq Copenhagen: ZEAL: Discovers and develops peptide-based medicines for metabolic and rare diseases.
Advanced degree (PhD preferred) in chemistry/chemical engineering, deep peptide process development expertise, leadership experience managing global technical teams, process optimization, synthetic route scouting, technology transfer to GMP and CMO management.
NewAmsterdam PharmaNASDAQ: NAMS: Develops oral non-statin medicines for cardiovascular and metabolic diseases.
12+ YOE12+ MgmtPhD in analytical chemistry or related,12+ years analytical team leadership in biotech/pharma,expertise in analytical method development/validation for API and DP,knowledge of ICH/FDA/EMA and GMP,CDMO oversight,and regulatory filing authorship.